Business Wire

Procore's Future State of Construction Report Reveals How AI, Automation, and Workforce Shifts are Shaping the Industry

Share

Procore Technologies, Inc. (NYSE: PCOR), a leading technology partner for every stage of construction, today released its first ever Future State of Construction Report, offering a data-driven look at the key trends and challenges shaping the construction industry across the next decade.

The inaugural report pairs extensive research and expert analysis from leading voices in the industry with survey data from over 1,200 construction decision-makers in Australia, Canada, Ireland, New Zealand, Saudi Arabia, United Arab Emirates, United Kingdom, and the United States. It offers a global, comprehensive view of emerging trends and challenges shaping the industry.

“The construction industry is at a turning point, and technology is the catalyst for its transformation,” said Procore Founder and CEO, Tooey Courtemanche. “AI, data and automation aren’t just driving efficiencies, they’re reshaping how we build, collaborate, and solve challenges. This is one of the most transformative periods in the history of construction, and at Procore, we’re committed to empowering the industry with the tools to navigate this future with confidence.”

Key Insights from the Future State of Construction Report:

  • AI and Automation are Eliminating Inefficiencies and Maximizing Productivity
    • AI and automation are poised to significantly enhance productivity in construction. 18% of project time is currently lost searching for data, and 28% is wasted due to rework.
    • 55% of construction leaders believe automation will disrupt the industry within the next five years. By integrating AI-driven preconstruction tools and automation, companies can help reduce inefficiencies, improve project planning, and boost ROI.
  • The Workforce is Changing – Upskilling and Well-Being are Critical
    • The construction workforce is undergoing a generational transformation. With 53% of workers expected to retire by 2036, companies are taking action to address this shift.
    • 47% of companies have upskilling programs in place, and 41% plan to implement them in the next year. These efforts are critical to attracting and retaining talent, especially as 60% of workers stay in construction for career growth and financial opportunities.
    • Additionally, 45% of workers cite burnout as the top reason they leave the industry, highlighting the importance of mental health support and well-being initiatives.
  • AI-Driven Insights are Reshaping Decision-Making
    • Over 80% of construction executives agree that connected historical data is crucial to project success, though 76% of civil and infrastructure builders acknowledge they are not yet fully harnessing the potential of their data.
    • AI-driven insights will optimize tasks like scheduling and workforce allocation, while human expertise will remain essential in applying these insights effectively.
  • Digital Tools are Empowering Builders to Lead the Design Process
    • 49% of construction professionals surveyed anticipate increased use of BIM for design collaboration and clash detection.
    • The design process is evolving as builders increasingly take the reins. Digital twins and AI-powered simulations will allow teams to optimize designs before construction even begins.

“Companies leveraging AI, automation, and data are continuing to unlock new efficiencies, enhance safety, and build a more resilient industry,” said Procore’s Global Technology Evangelist, Kris Lengieza. “However, at the core of every advancement in technology are the people who build. Their expertise and adaptability will determine how the industry evolves. At Procore, we believe that the future of construction isn't just about the technology, but about how we use it to build together. We’re committed to supporting the industry as it navigates this transformation.”

To download the full Future State of Construction Report, visit here.

About Procore

Procore Technologies, Inc. (NYSE: PCOR) is a leading technology partner for every stage of construction. Built for the industry, Procore’s unified technology platform drives efficiency and mitigates risk through AI & data-driven insights and decision making. Over three million projects have run on Procore across 150+ countries. For more information, visit www.procore.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250407799925/en/

Contacts

press@procore.com
investors@procore.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Intelsat Installs Multi-Orbit System on 130 Aircraft, Nearing 1000 Orders8.4.2025 10:00:00 EEST | Press release

Intelsat, operator of the world’s largest integrated satellite and terrestrial networks and leading provider of in-flight connectivity (IFC), installed its pioneering multi-orbit electronically steered array (ESA) system on 130 aircraft, delivering reliable, streaming connectivity to passengers aboard flights throughout North America. Intelsat has secured commitments for 1000 aircraft set to be equipped with the cutting-edge and operational multi-orbit solution. “This milestone underlines the fact that many airlines around the world are gravitating towards multi-orbit inflight connectivity solutions,” said Mike DeMarco, Chief Commercial Officer for Intelsat. “Passengers are already enjoying reliably fast service, based on our airline partners’ satisfaction scores, and we are excited to play a role in their success.” The successful launch of Intelsat's state-of-the-art multi-orbit system represents a major leap forward for in-flight connectivity technology, offering passengers unprecede

DATROWAY ® Approved in the EU for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer8.4.2025 09:30:00 EEST | Press release

DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medical Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast01 phase 3 trial. In TROPION-Breast01, DATROWAY significantly reduced the risk of disease progression or death by 37% compared to investigator’s choice of chemotherapy (hazard ratio [HR]=0.63; 95% confidence interval [CI]: 0.52-0

Bona Releases 2024 Sustainability Report8.4.2025 09:05:00 EEST | Press release

Bona, a global, family-owned company that supplies products for installing, renovating, maintaining, and restoring premium floors, has published its 2024 Sustainability Report. The report underscores Bona’s resilience in navigating a year of global challenges while advancing key sustainability initiatives. "Throughout 2024 Bona remained steadfast and resilient. Our commitment to sustainability has been a core driver of our innovation, helping us progress toward our environmental, social, and governance goals," said Kerstin Lindell, interim CEO and Chair of the Board, Bona. "We are proud to share the progress we’ve made in reducing our environmental impact, improving working conditions, and fostering greater transparency across our operations." Key Highlights from the 2024 Sustainability Report 41% Reduction in Greenhouse Gas (GHG) Emissions: Bona achieved a significant reduction in GHG emissions (Scope 1 and 2) compared to 2023, driven by renewable energy certificates in North America

POLYVANTIS Flies High at Aircraft Interiors Expo 2025 With Breakthrough Material Solutions That Meet Critical Industry Needs8.4.2025 09:00:00 EEST | Press release

POLYVANTIS, a leading multi-material sheet and film solutions supplier, will present its comprehensive product portfolio for aircraft interiors and glazing solutions at the Aircraft Interiors Expo. POLYVANTIS offers a wide range of films, sheets, and semi-finished products made from polymethyl methacrylate (PMMA), polyphenylsulfone (PPSU), polyetherimide (PEI), and polycarbonate (PC) that meet the high demands placed on materials for the aviation industry. POLYVANTIS serves its global customer base with the renowned brands EUROPLEX®, LEXAN™ PC film and sheet, and PLEXIGLAS® PMMA semi-finished products under one roof. “For decades, customers have relied on our brands for innovative material technologies, applications, and manufacturing processes to support the aircraft interiors industry,” said Peter Chedd, Director, Mass Transportation, Europe at POLYVANTIS. “We are proud to leverage our robust history and introduce our combined expertise as POLYVANTIS. Through products like ULTEM™ she

4Moving Biotech Secures €7.6M France 2030 Grant for Pioneering First-In-Class Disease-Modifying Osteoarthritis Drug8.4.2025 08:00:00 EEST | Press release

4Moving Biotech (4MB), a spin-off of 4P-Pharma developing the first potential disease-modifying drug (DMOAD) for knee osteoarthritis, announces that it has been awarded €7.6 million in funding under the France 2030 plan to accelerate the clinical development of its lead candidate, 4P004, currently in a Phase 2a trial. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407335930/en/ France 2030 is a highly selective and strategic initiative by the French government designed to fast-track the next generation of breakthrough innovations. 4MB's selection is a significant endorsement, granted through a rigorous, multi-stage evaluation process by leading scientific, clinical, and technological experts. This recognition highlights the robust scientific foundations of the 4P004 program and its potential to deliver a truly transformative therapy for OA's unmet medical need and significant socio-economic impact with over 600 million pe

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye